European journal of clinical pharmacology
-
Eur. J. Clin. Pharmacol. · Mar 2016
Review Meta AnalysisFirst-line therapy for non-transplant eligible patients with multiple myeloma: direct and adjusted indirect comparison of treatment regimens on the existing market in Germany.
The purpose of this study was to compare approved first-line therapies for patients with multiple myeloma. ⋯ VMP and MPT seem more effective than MP, VMP was superior to MPT regarding response criteria and AEs. Our results may best be confirmed by a head-to-head trial of VMP vs. MPT.